Gene Editing to
Revolutionize Biotech

November 8, 2011

C4U and Nippon Gene have entered into a non-exclusive sublicense agreement granting Nippon Gene develop, manufacture and sell reagents utilizing CRISPR-Cas3 technology.

October 22, 2021

The patent for the invention, “A method for detecting specific DNA in the sample”, was issued by Japan Patent Office.
Patent registration number: No. 6940086

October 22, 2021

The patent for the invention, “GENOME EDITING METHOD”, was issued by Japan Patent Office.
Patent registration number: No. 6948718

October 13-15, 2021

C4U will participate in BIO JAPAN at PACIFICO Yokohama (JHVS booth V-44).
Our CEO Hirai will give a presentation at the pitch event on October 14, 2021 at 2pm.

October 7-8, 2021

C4U is participating in the 21st Annual Biotech in Europe Forum (BEF), a global bio-pharma industry partnering and investment event that will be held online on October 7-8, 2021.

©2019 C4U Corporation